These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37673131)

  • 1. Neuroprotection by agmatine: Possible involvement of the gut microbiome?
    Saha P; Panda S; Holkar A; Vashishth R; Rana SS; Arumugam M; Ashraf GM; Haque S; Ahmad F
    Ageing Res Rev; 2023 Nov; 91():102056. PubMed ID: 37673131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new target for diagnosis and treatment of CNS disorders: agmatinergic system.
    Uzbay T
    Curr Med Chem; 2012; 19(30):5116-21. PubMed ID: 22934767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of agmatine in neurodegenerative diseases and epilepsy.
    Moretti M; Matheus FC; de Oliveira PA; Neis VB; Ben J; Walz R; Rodrigues AL; Prediger RD
    Front Biosci (Elite Ed); 2014 Jun; 6(2):341-59. PubMed ID: 24896210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Role of Agmatine in Neurological Diseases.
    Xu W; Gao L; Li T; Shao A; Zhang J
    Curr Neuropharmacol; 2018; 16(9):1296-1305. PubMed ID: 28786346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of agmatine: An in-depth overview.
    Rafi H; Rafiq H; Farhan M
    Neuropeptides; 2024 Jun; 105():102429. PubMed ID: 38608401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agmatine : metabolic pathway and spectrum of activity in brain.
    Halaris A; Plietz J
    CNS Drugs; 2007; 21(11):885-900. PubMed ID: 17927294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF/cREB and ERK pathway.
    Bilge SS; Günaydin C; Önger ME; Bozkurt A; Avci B
    Behav Brain Res; 2020 Aug; 392():112692. PubMed ID: 32479847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape.
    Watts D; Pfaffenseller B; Wollenhaupt-Aguiar B; Paul Géa L; Cardoso TA; Kapczinski F
    Expert Opin Ther Targets; 2019 Apr; 23(4):327-339. PubMed ID: 30764678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic strategies for the degradation of the neuromodulator agmatine in mammals.
    Benítez J; García D; Romero N; González A; Martínez-Oyanedel J; Figueroa M; Salas M; López V; García-Robles M; Dodd PR; Schenk G; Carvajal N; Uribe E
    Metabolism; 2018 Apr; 81():35-44. PubMed ID: 29162499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective offerings by agmatine.
    Kotagale NR; Taksande BG; Inamdar NN
    Neurotoxicology; 2019 Jul; 73():228-245. PubMed ID: 31063707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of the Neuroprotective Function of the Amino Group Blocked Fluorescence-Agmatine.
    Barua S; Sim AY; Kim JY; Shin I; Lee JE
    Neurochem Res; 2021 Aug; 46(8):1933-1940. PubMed ID: 33914233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression.
    Meylan EM; Breuillaud L; Seredenina T; Magistretti PJ; Halfon O; Luthi-Carter R; Cardinaux JR
    Transl Psychiatry; 2016 Jul; 6(7):e852. PubMed ID: 27404284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidences for agmatine alterations in Aβ
    Dixit MP; Rahmatkar SN; Raut P; Umekar MJ; Taksande BG; Kotagale NR
    Neurosci Lett; 2021 Jan; 740():135447. PubMed ID: 33127446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological importance of agmatine in the brain.
    Uzbay TI
    Neurosci Biobehav Rev; 2012 Jan; 36(1):502-19. PubMed ID: 21893093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain.
    Reis DJ; Regunathan S
    J Auton Nerv Syst; 1998 Oct; 72(2-3):80-5. PubMed ID: 9851555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.
    Zhu MY; Wang WP; Cai ZW; Regunathan S; Ordway G
    Eur J Neurosci; 2008 Mar; 27(6):1320-32. PubMed ID: 18364017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The agmatine-degrading enzyme agmatinase: a key to agmatine signaling in rat and human brain?
    Bernstein HG; Derst C; Stich C; Prüss H; Peters D; Krauss M; Bogerts B; Veh RW; Laube G
    Amino Acids; 2011 Feb; 40(2):453-65. PubMed ID: 20563878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter.
    Reis DJ; Regunathan S
    Ann N Y Acad Sci; 1999 Jun; 881():65-80. PubMed ID: 10415899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of an agmatinase-like protein in the rat brain.
    Mella C; Martínez F; de Los Angeles García M; Nualart F; Castro V; Bustos P; Carvajal N; Uribe E
    Histochem Cell Biol; 2010 Aug; 134(2):137-44. PubMed ID: 20607275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic and nutraceutical potential of agmatine, and its enhanced production using Aspergillus oryzae.
    Akasaka N; Fujiwara S
    Amino Acids; 2020 Feb; 52(2):181-197. PubMed ID: 30915570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.